我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
1
0 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
2010
已完成
100.0%
暂无批准数据
- Toronto-based biotech company Radiant Biotherapeutics has named Deborah Geraghty, Ph.D., as President and Chief Executive Officer to lead the company's next phase of growth. - Dr. Geraghty brings over 20 years of financial, operational, and strategic experience in biopharmaceutical leadership, having previously served as President and CEO of Anokion SA. - The company also appointed Stefan Larson, Ph.D., as Chair of the Board of Directors and Ingmar Bruns, M.D., Ph.D., as Board Member to strengthen its leadership team. - The new leadership appointments position Radiant Biotherapeutics for strategic expansion under experienced biotechnology industry executives.
